PerspectiveKidney Disease

Rituximab’s New Therapeutic Target: The Podocyte Actin Cytoskeleton

See allHide authors and affiliations

Science Translational Medicine  01 Jun 2011:
Vol. 3, Issue 85, pp. 85ps21
DOI: 10.1126/scitranslmed.3002429

Log in to view PDF

Log in through your institution

Log in through your institution